DNA Synthesis
Stemnovate is soon introducing a microfluidic platform for DNA synthesis. This disruptive technology allows template free DNA/RNA synthesis that can potentially accelerate the development of new therapeutics in the pharmaceutical sector, e.g. antibody research, drug bio-production and RNAi based therapeutics. This microfluidic platform technology overcomes the current limitations of DNA synthetic technology.
Applications
DNA synthesis has the potential to revolutionise the field of drug discovery, biotechnology, nanotechnology and oligonucleotides synthesis.
Drug Discovery
The applications are varied, such as RNA therapy, antibody research and vaccine development.
Biotechnology
DNA synthesis helps facilitate drug bio-production, biofuel research, crop production and research for food security.
Nanotechnology
DNA synthesis is being explored for novel DNA data storage and nano-material discoveries.
Platform Features
Accuracy
Precision DNA synthesis and high yield with purity harnessing novel enzymatic methodology.
Scalability
The faster synthesis method surpasses conventional technology for achieving longer product size.
Eco-Friendly
The technology is environmentally friendly with no impact from any harmful reagents.
Speed
Rapid template free-Enzymatic DNA Synthesis for short and long oligos.
How It Works
Advantages Of Stemnovate’s ETFDS
| Parameters | Stemnovate’s enzymatic DNA synthesis platform. | Chemical DNA synthesis and Centralized services. |
|---|---|---|
| Length | ETFDS is capable of generating short to long to ultra-long DNA. | Phosphoramidite synthetic DNA is limited to < 150mers for a polynucleotide strand. |
| Quality | High quality with low impurities. | Level of impurities increases as DNA length exceeds >150mers. |
| Synthesis Method | Uses natural enzymes in aqueous solution. | Uses harsh environmentally unfriendly chemicals. |